(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.89%) $83.10
(-1.16%) $1.619
(-0.29%) $2 340.40
(-0.42%) $27.42
(0.57%) $927.40
(-0.14%) $0.933
(-0.08%) $11.02
(-0.22%) $0.799
(0.00%) $92.17
-0.83% INR 1 592.70
Live Chart Being Loaded With Signals
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally...
Stats | |
---|---|
Tagesvolumen | 3 848.00 |
Durchschnittsvolumen | 21 036.00 |
Marktkapitalisierung | 22.51B |
EPS | INR0 ( 2024-02-01 ) |
Nächstes Ertragsdatum | ( INR0 ) 2024-05-20 |
Last Dividend | INR10.00 ( 2023-07-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 34.66 |
ATR14 | INR1.547 (0.10%) |
Volumen Korrelation
TTK Healthcare Limited Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
TTK Healthcare Limited Korrelation - Währung/Rohstoff
TTK Healthcare Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR7.25B |
Bruttogewinn: | INR3.77B (52.04 %) |
EPS: | INR452.73 |
FY | 2022 |
Umsatz: | INR7.25B |
Bruttogewinn: | INR3.77B (52.04 %) |
EPS: | INR452.73 |
FY | 2022 |
Umsatz: | INR5.96B |
Bruttogewinn: | INR3.09B (51.85 %) |
EPS: | INR13.10 |
FY | 2021 |
Umsatz: | INR6.37B |
Bruttogewinn: | INR3.83B (60.10 %) |
EPS: | INR32.87 |
Financial Reports:
No articles found.
TTK Healthcare Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR3.50 | 2010-07-16 |
Last Dividend | INR10.00 | 2023-07-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | INR73.00 | -- |
Avg. Dividend % Per Year | 0.72% | -- |
Score | 1.73 | -- |
Div. Sustainability Score | 1.790 | |
Div.Growth Potential Score | 3.58 | |
Div. Directional Score | 2.69 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR5.00 | 0.48% |
2019 | INR5.00 | 0.63% |
2020 | INR3.00 | 0.61% |
2021 | INR6.00 | 1.03% |
2022 | INR10.00 | 1.40% |
2023 | INR10.00 | 0.98% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATACONSUM.NS | Dividend Junior | 2023-05-19 | Annually | 26 | 0.60% | |
NIPPOBATRY.NS | Dividend Junior | 2023-09-20 | Annually | 23 | 1.06% | |
INDIANB.NS | Dividend Junior | 2023-06-12 | Annually | 18 | 1.99% | |
CIPLA.NS | Dividend Junior | 2023-07-20 | Annually | 28 | 0.41% | |
SANGHVIMOV.NS | Dividend Junior | 2023-08-04 | Sporadic | 18 | 0.41% | |
M&MFIN.NS | Dividend Junior | 2023-07-20 | Annually | 19 | 1.20% | |
GLOBUSSPR.NS | Dividend Junior | 2023-07-14 | Sporadic | 15 | 0.36% | |
ASTEC.NS | No Dividend Player | 2023-07-20 | Annually | 15 | 0.08% | |
TIPSINDLTD.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.03% | |
PEL.NS | Dividend Junior | 2023-06-16 | Annually | 29 | 1.59% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0818 | 1.500 | 8.36 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.128 | 1.500 | 9.69 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 26.92 | 1.000 | 1.142 | 1.142 | [3 - 30] |
operatingCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 7.90 | [0 - 30] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 0.929 | 1.857 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.547 | 1.000 | 4.22 | 4.22 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0995 | 1.000 | -0.00989 | -0.00989 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 1.790 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 36.59 | 1.000 | 6.41 | 0 | [1 - 100] |
returnOnEquityTTM | 0.128 | 2.50 | 9.80 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 1.857 | [0 - 30] |
dividendYielPercentageTTM | 0.628 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 7.90 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0254 | 1.500 | -3.16 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0341 | 1.000 | -1.648 | 0 | [0.1 - 0.5] |
Total Score | 3.58 |
TTK Healthcare Limited
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.